Therapeutic Solutions International Inc (TSOI)
Therapeutic Solutions International, Inc. is a healthcare company focused on immune modulation for a range of conditions in the United States. The company develops immune-modulatory agents and related products aimed at cancers, schizophrenia, suicidal ideation, traumatic brain injury, chronic traumatic encephalopathy, and lung pathology, as well as daily health applications. Its product lineup includes QuadraMune, a patented blend designed to support natural killer cell activity and healthy cytokine production, along with nutraceuticals such as ProJuvenol, NanoStilbene, DermalStilbene, IsoStilbene, NeuroStilbene, NanoPSA, and NLRP3 Trifecta. Therapeutic Solutions International also develops immunotherapies, including dendritic cell vaccines for cancers and Parkinson’s disease through its StemVacs platform. The company was founded in 2007 and is headquartered in Elk City, Idaho.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-TSOI
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
7.049 K
|
—
|
—
|
—
|
—
|
—
|
—
|
